Literature DB >> 16733337

Olfactory disorders following upper respiratory tract infections.

Antje Welge-Lüssen1, Markus Wolfensberger.   

Abstract

Postviral olfactory disorders usually occur after an upper respiratory tract infection (URTI) associated with a common cold or influenza. With a prevalence between 11 and 40% they are among the common causes of olfactory disorders. Women are more often affected than men and post-URTI disorders usually occur between the fourth and eighth decade of life. The exact location of the damage in post-URTI is not yet known even though from biopsies a direct damage of the olfactory receptor cells is very likely. Nevertheless, central mechanisms cannot completely be ruled out. The diagnosis is made according to the history, clinical examination and olfactory testing. Affected patients usually recall the acute URTI and a close temporal connection should be present to establish the diagnosis. Spontaneous recovery might occur within 2 years. So far, no effective therapy exists even though specific olfactory training might be promising.

Entities:  

Mesh:

Year:  2006        PMID: 16733337     DOI: 10.1159/000093758

Source DB:  PubMed          Journal:  Adv Otorhinolaryngol        ISSN: 0065-3071


  50 in total

1.  Cranial nerve I: olfaction.

Authors:  Richard D Sanders; Paulette Marie Gillig
Journal:  Psychiatry (Edgmont)       Date:  2009-07

2.  Quantitative Analysis of the Olfactory System in COVID-19: An MR Imaging Study.

Authors:  E Altunisik; A H Baykan; S Sahin; E Aydin; S M Erturk
Journal:  AJNR Am J Neuroradiol       Date:  2021-09-23       Impact factor: 3.825

Review 3.  Olfactory and gustatory disorders in COVID-19.

Authors:  Ludger Klimek; Jan Hagemann; Julia Döge; Laura Freudelsperger; Mandy Cuevas; Felix Klimek; Thomas Hummel
Journal:  Allergo J Int       Date:  2022-06-20

4.  Smell Changes and Efficacy of Nasal Theophylline (SCENT) irrigation: A randomized controlled trial for treatment of post-viral olfactory dysfunction.

Authors:  Jake J Lee; Andrew M Peterson; Dorina Kallogjeri; Pawina Jiramongkolchai; Sara Kukuljan; John S Schneider; Cristine N Klatt-Cromwell; Andrew J Drescher; Joseph D Brunworth; Jay F Piccirillo
Journal:  Am J Otolaryngol       Date:  2021-12-03       Impact factor: 2.873

5.  Neuroinflammation resulting from covert brain invasion by common viruses - a potential role in local and global neurodegeneration.

Authors:  Jeannine A Majde
Journal:  Med Hypotheses       Date:  2010-03-16       Impact factor: 1.538

Review 6.  COVID-19 and Parkinson's disease: Defects in neurogenesis as the potential cause of olfactory system impairments and anosmia.

Authors:  Harini Sri Rethinavel; Sowbarnika Ravichandran; Risna Kanjirassery Radhakrishnan; Mahesh Kandasamy
Journal:  J Chem Neuroanat       Date:  2021-05-11       Impact factor: 3.052

7.  Clinical, sinonasal, and long-term smell and taste outcomes in mildly symptomatic COVID-19 patients.

Authors:  Amjed Tarifi; Amjad A Al Shdaifat; Abdel-Ellah M Al-Shudifat; Mohammed Azab; Ja'far Ismail; Rand Bashir; Aous Amro; Ahmad Altarifi; Yousef Khader
Journal:  Int J Clin Pract       Date:  2021-04-29       Impact factor: 3.149

8.  Comparison of the Healing Effect of Nasal Saline Irrigation with Triamcinolone Acetonide Versus Nasal Saline Irrigation alone in COVID-19 Related Olfactory Dysfunction: A Randomized Controlled Study.

Authors:  Erkan Yildiz; Selcen Koca Yildiz; Selçuk Kuzu; Çağlar Günebakan; Abdulkadir Bucak; Orhan Kemal Kahveci
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2021-07-10

9.  An olfactory demography of a diverse metropolitan population.

Authors:  Andreas Keller; Margaret Hempstead; Iran A Gomez; Avery N Gilbert; Leslie B Vosshall
Journal:  BMC Neurosci       Date:  2012-10-10       Impact factor: 3.288

10.  Furthering the understanding of olfaction, prevalence of loss of smell and risk factors: a population-based survey (OLFACAT study).

Authors:  Joaquim Mullol; Isam Alobid; Franklin Mariño-Sánchez; Llorenç Quintó; Josep de Haro; Manuel Bernal-Sprekelsen; Antonio Valero; Cèsar Picado; Concepció Marin
Journal:  BMJ Open       Date:  2012-11-06       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.